EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells

Moisés E Bauer, Antônio L Teixeira

Neuroimmunomodulation · 2021 · 28 (3) · 99-107

DOI: 10.1159/000515594 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuroimmunomodulation, online erschienen am 05.05.2021. Verfasst von Moisés E Bauer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunobiology, School of Health and Life Sciences, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Bipolar Disorder, Major Depressive Disorder. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mood disorders are associated with chronic low-grade systemic (sterile) inflammation, with increased plasma levels of pro-inflammatory mediators targeting all tissues including the brain. Importantly, pro-inflammatory cytokines (ex., tumor-necrosis factor alpha [TNF-α], interleukin [IL]-6) regulate mood behavior and cognition by influencing neurotransmitter levels, activating stress-responsive endocrine axes, among other effects. However, the mechanisms underlying this enhanced inflammation are not well understood. There is increasing evidence indicating that impaired immunoregulatory mechanisms may play a role in this context. Patients with mood disorders (major depression [MDD] and bipolar disorder [BD]) have reduced numbers of major regulatory cells of both innate (natural killer regulatory cells and myeloid-derived suppressor cells [MDSCs]) and adaptive immune responses (CD4+CD25+FoxP3+, B regulatory cells). Dysfunctional regulatory immune cells might contribute to systemic and neuroinflammation observed in mood disorders via different mechanisms, such as: (i) failure to develop adequate stress-related responses, (ii) indirectly through microglial activation, (iii) lack of trophic support and pro-cognitive functions of T cells in the brain, and (iv) dysbiosis. In conclusion, maladaptive immunoregulatory mechanisms seem to be involved with both onset and progression of mood disorders. A deeper understanding of these mechanisms may lead to the development of new therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderMajor Depressive DisorderCytokinesHumansInflammationMood Disorders

Stichwörter der Autor:innen

Bipolar disorderCytokinesInflammationMajor depressive disorderNeuroinflammationRegulatory T cells

Substanzen

Cytokines

Autor:innen und Institutionen

  • Laboratory of Immunobiology, School of Health and Life Sciences, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.
  • National Institute of Science and Technology - Neuroimmunomodulation (INCT-NIM), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brasília, Brazil.
  • Institute of Education and Research, Santa Casa BH, Belo Horizonte, Brazil.
  • Neuropsychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas, USA.

Zitieren

APA

Bauer, M. E., & Teixeira, A. L. (2021). Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells. Neuroimmunomodulation, 28(3), 99-107. https://doi.org/10.1159/000515594

Vancouver

Bauer ME, Teixeira AL. Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells. Neuroimmunomodulation. 2021;28(3):99-107. doi:10.1159/000515594

BibTeX
@article{Bauer2021,
  author = {Bauer, Moisés E and Teixeira, Antônio L},
  title = {Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells},
  journal = {Neuroimmunomodulation},
  year = {2021},
  volume = {28},
  number = {3},
  pages = {99--107},
  doi = {10.1159/000515594}
}
Kostenlos starten →